Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma

Title
Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 17, Issue 22, Pages 6958-6962
Publisher
American Association for Cancer Research (AACR)
Online
2011-09-08
DOI
10.1158/1078-0432.ccr-11-1595

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started